CSI Market
Sign In | Register

Ekso Bionics Holdings Inc (EKSO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access EKSO quarterly Cash Flow →
This page allows investors to follow Ekso Bionics Holdings Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(May 31 2025)
12 Months 		(Dec 31 2025) (Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Operating Activities
Income-72.73
Depreciation & amortization80.66
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed9.51
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.41
Share-based Compensation-1.46
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Amortization Of Deferred Charges-
Liabilities Fair Value Adjustment-
Derivative Gain Loss On Derivative Net0.00
Warrant Issuance Expense-
Interest Income Other-
Amortization Of Deferred Rent-
Gain Loss On Warrant Liability-
Gain Loss On Change In Fair Value Contingent Liabilities-
Common Stock Contribution0.15
Fair Value Of Warrants Issued Upon Equity Financing-
Reclassifications Of Temporary To Permanent Equity-
Impairment Of Intangible Assets Excluding Goodwill-0.78
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable3.79
Increase (Decrease) in Accounts Payable-9.01
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-1.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.11
Other Working Capital-0.58
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-16.68
Discontinued operations0.00
Net Cash flow from Operating Activities-7.22
Investing Activities
Capital Expenditures-1.38
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.38
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions113.74
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-102.74
Shareholder Loans To Finance Leveraged Buyout-
Proceeds From Convertible Debt Two-
Proceeds From Issuance Of Common Stock Preference Stock And Warrants-
Proceeds From Issuance Of Preferred Stock And Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities11.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-8.60
Total Cash Flow2.40
4 historic quarters locked

Sign in to unlock the full Ekso Bionics Holdings Inc cash flow history.

Sign In Create Free Account

About Chronoscale Holdings Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-058018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License